Fundamental study on the implantable LH-RH agonist/polymer and its use in a randomized trial for prostate cancer.
Yamanaka
H
H
Department of Urology, Gunma University School of Medicine.
Imai
K
K
Mashimo
T
T
Yuasa
H
H
Yoshida
M
M
Asano
M
M
Fukuzaki
H
H
KumaKura
M
M
D000818:Animals; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D004343:Drug Implants; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D007773:Lactates; D019344:Lactic Acid; D008297:Male; D011091:Polyesters; D011108:Polymers; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D051381:Rats; D011919:Rats, Inbred Strains; D011966:Receptors, LHRH / Q000187:drug effects*; D005641:Tegafur / Q000008:administration & dosage; D014498:Uracil / Q000008:administration & dosage
D004343:Drug Implants; D007773:Lactates; D011091:Polyesters; D011108:Polymers; D011966:Receptors, LHRH; D005641:Tegafur; D019344:Lactic Acid; C033616:poly(lactide); D014498:Uracil